High claim volume, razor-thin per-test margins, panel-unbundling traps and strict medical-necessity policies make lab billing a precision game. Helix codes panels correctly, scrubs every claim against NCCI/MUE, and maps diagnoses to LCDs before submission.
Clean-claim rate
Avg. net revenue lift
Days in A/R
Denials overturned
Labs run thousands of low-dollar claims a day, so a single recurring error — an unbundled panel, an MUE-busting unit count, a missing ordering diagnosis — multiplies into six-figure leakage before anyone notices.
Helix treats the edit logic as the product: panels coded as panels, units validated against MUEs, diagnoses mapped to LCDs, and CLIA and ordering-provider data complete on every claim that leaves the building.
Organ/disease panels billed correctly, never itemized into denials.
PLA, Tier 1/2 and stacked-code testing billed to payer policy.
Diagnosis-to-policy mapping and ABN handling up front.
CLIA number, ordering NPI and dx complete before submission.
From routine chemistry to molecular assays, each line carries its own panel, MUE and necessity rules. We keep every one accurate at volume.
| 80053 | Comprehensive metabolic panel | panel |
| 80061 | Lipid panel | panel |
| 85025 | CBC with auto differential | MUE 1 |
| 87635 | SARS-CoV-2 amplified probe | LCD |
| 81001 | Urinalysis, automated w/ microscopy | -QW |
| 88305 | Surgical pathology, level IV | -26/-TC |
Panel components billed individually, bundled by NCCI and paid at a fraction of the panel.
Helix fix: panel-rollup logic codes organ/disease panels as a single correct CPT.
Unit count tops the Medically Unlikely Edit for the test, truncating or denying payment.
Helix fix: MUE validation flags over-limit units and applies the right modifier or split.
Ordering diagnosis doesn't support the test under the applicable LCD/NCD policy.
Helix fix: diagnosis-to-LCD mapping and ABN workflow before the claim drops.
Claim lacks the CLIA certificate number or a valid ordering-provider NPI/diagnosis.
Helix fix: required-field gate blocks any claim missing CLIA, ordering NPI or dx.
CLIA, ordering NPI and diagnosis validated at accession.
Tests rolled into correct panels and molecular code stacks.
Edits and medical-necessity policies applied pre-submission.
Bundling appeals, reprocessing and aged-A/R workdown.
"We were bleeding margin on unbundled panels and MUE denials we never caught at our volume. Helix rebuilt the edit logic and it showed up in the first month."
A reference lab running tens of thousands of claims monthly with chronic panel-unbundling, MUE truncations and molecular codes denied for missing LCD support.
Helix deployed panel-rollup and MUE validation, mapped molecular and clinical tests to payer LCDs, gated CLIA/ordering-data completeness, and ran a 90-day bundling-denial recovery.
Clean-claim rate reached 99.2%, A/R days fell to 19, the lab recovered $512K in aged claims, and net revenue rose 21%.
Representative composite based on Helix engagement outcomes. Individual results vary.
"Our -26/-TC splits were a constant denial source. Helix fixed the professional/technical logic and the denials stopped."
Result: $214K recovered in year one.
"Payers kept denying our genetic panels for necessity. The LCD mapping turned that around almost overnight."
Result: +$38K average monthly molecular revenue.
Representative composites based on Helix engagement outcomes. Individual results vary.
Get a free audit of your panel coding, NCCI/MUE edits, LCD mapping and aged A/R, and a clear picture of the margin you could be recovering.